Neurological Associates, Inc.

Richmond, Virginia 23230

0 studies enrolling now · 9 studies all time

What they study most

Acute Brainstem/Cerebellar Syndrome, Alzheimer Disease, Alzheimer's Disease, Autoimmune Diseases of the Nervous System, Brain Atrophy, Cognition Disorders, Disease Progression, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis, Orthostatic Hypotension

Studies at this site

• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis — Completed
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis — Completed
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 — Completed
• Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed